Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Emma Walmsley

National Institute for Health and Care Excellence NICE logo

Amicus gets NICE green light for Fabry drug

Oral therapy alternative Galafold approved for routine NHS use

- PMLiVE

PM Society appoints new chairman

Craig Bradley succeeds Rachel Farrow and Carwyn Jones

- PMLiVE

Adelphi Research UK promotes Claire Nelson and Steve Loasby

Become research director and research manager, respectively

- PMLiVE

Illumina expands board of directors

John Thompson brings experience from IBM and Microsoft

Former Novartis vaccines CMO joins Arterial

Dr Markus Weissbach becomes clinical trials director

Greenleaf Health appoints drug and biological products principal

Dr John Jenkins joins the FDA regulatory consulting firm

- PMLiVE

BioMarin’s chief commercial officer joins True North’s board

Jeff Ajer brings over 20 years of industry experience to the biotech

ABPI London offices

Norgine UK re-joins ABPI

Firm resigned its membership in 2008 in protest over lack of representation

- PMLiVE

Gilead Sciences appoints general manager, Canada

Nordics general manager Kennet Brysting moves to take up new post

- PMLiVE

BlackThorn Therapeutics appoints CEO

Gregory Vontz joins from Topica Pharmaceuticals

Lilly elects Prof Carolyn Bertozzi to board of directors

She brings oncology, inflammation and infection research expertise to the firm

- PMLiVE

Therachon strengthens management team

Dr Hans Schikan, Dr Richard Porter and Dr Jeffrey Stavenhagen join

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links